Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Growth Metrics

Others

Cost of Revenue EBIAT Gross Profit Loans and Notes Receivables Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments R&D In Process Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Short-Term Debt repayments

Odyssey Health (ODYY) Long-Term Debt Repayments (2021)

Odyssey Health has reported Long-Term Debt Repayments over the past 3 years, most recently at -$198201.0 for Q3 2021.

For Q3 2021, Long-Term Debt Repayments changed N/A year-over-year to -$198201.0; the TTM value through Jul 2021 reached $107269.0, changed N/A, while the annual FY2024 figure was $274896.0, 685.42% up from the prior year.
Long-Term Debt Repayments for Q3 2021 was -$198201.0 at Odyssey Health, down from $209116.0 in the prior quarter.
Over five years, Long-Term Debt Repayments peaked at $209116.0 in Q2 2021 and troughed at -$198201.0 in Q3 2021.